CAV1 has been widely studied in metabolic syndrome disorders such as dyslipidemia and CVD due to signal transduction, trafficking in cholesterol hemostasis, and triacylglycerol metabolism (Jin et al., 2011). This evidence concerns the gene CAV1 and metabolic syndrome.